Wegovy injection is approved to aid adults and adolescents aged 12 years and older dealing with obesity, or adults with excessive weight (overweight) accompanied by weight-related medical conditions
I see a new Doc at the end of the month where Im sure Ill get blood work
Activation of GLP-1R by exendin-4 promoted the osteogenic differentiation, increased bone formation and osteoblast number and inhibited BMSC adipogenic differentiation, but wortmannin (PI3K inhibitor), and GLP-1R sh-RNA partially blocked the exendin-4-induced PI3K/AKT signaling activation and attenuated the facilitating effect of exendin-4 in BMSCs (Figure 1)
It is a provider-administered treatment tied to antioxidant activity, cellular support, and wellness-focused care
Dose Range: 3301000 mcg total blend per day, raised gradually
Some users report minor digestive changes, particularly with higher doses